BiOnSil Overview

  • Founded
  • 2010
  • Status
  • Out of Business
  • Latest Deal Type
  • Liquidation

BiOnSil General Information


Developer of diagnostic and theranostic kits intended to offer diagnosis of drug resistance in colorectal cancer. The company's diagnostic and theranostic kits helps in identification of patients with a predisposition of colon-cancer resistance toward chemotherapy drugs, enabling physicians to treat the patients efficiently.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Via Gaetano Donizetti 47
  • 20122 Milan
  • Italy
+39 02 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BiOnSil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 00.00 Completed Bankruptcy: Liquidation
1. Early Stage VC 00.00 00.00 Completed Startup
To view BiOnSil’s complete valuation and funding history, request access »

BiOnSil Executive Team (1)

Name Title Board Seat Contact Info
Lavitrano Marialuisa Chief Executive Officer
To view BiOnSil’s complete executive team members history, request access »